Ameritas Investment Partners, Inc. Neogenomics Inc Transaction History

Ameritas Investment Partners, Inc.

$2.98 Billion
Q3 2024

A detailed history of Ameritas Investment Partners, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 12,476 shares of NEO stock, worth $205,729. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,476

Previous 13,191 5.42%

Holding current value

$205,729

Previous $182,000 1.1%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$13.4 - $17.73 $9,581 - $12,676	-715 Reduced 5.42%	12,476 $184,000
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $6,185 - $10,986	530 Added 4.19%	13,191 $213,000
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $25,976 - $38,163	2,138 Added 20.32%	12,661 $155,000
Q2 2023 Aug 11, 2023	BUY	$14.1 - $19.83 $9,221 - $12,968	654 Added 6.63%	10,523 $169,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $8,182 - $13,439	1,041 Added 11.79%	9,869 $84,000
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $10,776 - $13,115	-324 Reduced 3.54%	8,828 $326,000
Q2 2020 Aug 05, 2020	BUY	$24.21 - $31.02 $14,114 - $18,084	583 Added 6.8%	9,152 $284,000
Q1 2020 May 13, 2020	BUY	$20.5 - $34.53 $5,719 - $9,633	279 Added 3.37%	8,569 $237,000
Q4 2019 Feb 13, 2020	BUY	$18.96 - $29.84 $6,844 - $10,772	361 Added 4.55%	8,290 $242,000
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $9,158 - $12,568	479 Added 6.43%	7,929 $152,000
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $13,366 - $16,460	683 Added 10.09%	7,450 $163,000
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $18,634 - $31,406	1,535 Added 29.34%	6,767 $138,000
Q4 2018 Feb 12, 2019	BUY	$11.24 - $18.5 $12,364 - $20,350	1,100 Added 26.62%	5,232 $66,000
Q2 2017 Aug 15, 2017	BUY	N/A	4,132	4,132 $37,000

Others Institutions Holding NEO

# of Institutions

294

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.07B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Neogenomics Inc Transaction History